Overview A Study of LY2216684 in Healthy Participants Status: Completed Trial end date: 2011-09-01 Target enrollment: Participant gender: Summary This study will evaluate the pharmacodynamic and pharmacokinetic interaction of LY2216684 with alcohol in healthy participants. This study will run approximately for 34 days. Phase: Phase 1 Details Lead Sponsor: Eli Lilly and CompanyTreatments: EthanolPhenylethyl Alcohol